depending on which medication people took with Kisqali. For example, people who took Kisqali with Femara reported difficulty sleeping as a side effect. But this wasn’t reported by people who ...
The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It ...
Hepatic impairment: reduce Kisqali to 400mg once daily (moderate and severe); Femara 2.5mg every other ... Avoid concomitant with drugs known to prolong QT interval (eg, amiodarone, bepridil ...
The breast cancer drug Kisqali has received FDA approval to reduce cases of cancer recurrence. The drug was found to reduce ...
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease, drugmaker Novartis said Tuesday.
Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease, following the ...
Kisqali has been FDA-approved with an aromatase inhibitor as postsurgical treatment for some with early breast cancer at a ...
Unlike rival CDK 4/6 inhibitor abemaciclib, patients don't need to be lymph-node positive to receive ribociclib after surgery ...
Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment. Serious. These medicines may interact and cause very harmful effects.
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease, drugmaker Novartis said Tuesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback